Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions

Pharmacokinetics in Healthy Adults

Interventions

DRUG

5-MeO-DMT

A single dose of 5-MeO-DMT will be administered intranasally

OTHER

Placebo

A single dose of placebo will be administered intranasally

Trial Locations (1)

King's College London, London